RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $268,086 | -33.0% | 31,877 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $400,380 | +7.5% | 31,877 | +41.0% | 0.00% | 0.0% |
| Q1 2023 | $372,470 | +10.2% | 22,615 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $337,868 | -19.4% | 22,615 | +61.5% | 0.00% | 0.0% |
| Q1 2022 | $419,000 | -2.6% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $430,000 | -16.0% | 14,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $512,000 | +5.8% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $484,000 | -16.8% | 14,000 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $582,000 | -2.3% | 14,000 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $596,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |